Quinazolinone modulators of nuclear receptors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8748440
APP PUB NO 20120064025A1
SERIAL NO

13247328

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds, pharmaceutical compositions and methods for modulating the activity of nuclear receptors are provided. In particular, quinazolinones are provided for modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AKARNA THERAPEUTICS LTDST JOHN'S INNOVATION CENTRE COWLEY ROAD CAMBRIDGE CB4 0WS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Flatt, Brenton T Poway, US 22 479
Griffith, Ronald Escondido, US 5 125
Kahl, Jeffrey D San Diego, US 5 45
Martin, Richard San Diego, US 208 2688

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00